Moreover, the chaperone HSP40/HSP70 axis is responsible for the regulation of the GR receptor, the significantly increased expression of which has been confirmed in enzulamide-resistant CRPC, which is an alternative mechanism of tumor cell resistance to AR-targeted therapies. This evidence concerns the gene DNAJB1 and neoplasm.